Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway.
Weg-Remers S, Ponta H, Herrlich P, König H. Weg-Remers S, et al. EMBO J. 2001 Aug 1;20(15):4194-203. doi: 10.1093/emboj/20.15.4194. EMBO J. 2001. PMID: 11483522 Free PMC article.
CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor.
Herrlich P, Morrison H, Sleeman J, Orian-Rousseau V, König H, Weg-Remers S, Ponta H. Herrlich P, et al. Ann N Y Acad Sci. 2000 Jun;910:106-18; discussion 118-20. doi: 10.1111/j.1749-6632.2000.tb06704.x. Ann N Y Acad Sci. 2000. PMID: 10911909 Review.
Antagonistic signaling pathways regulate alternative splicing of CD44 in T cells.
Weg-Remers S, Ponta H, Herrlich P, König H. Weg-Remers S, et al. Ann N Y Acad Sci. 2002 Nov;973:112-5. doi: 10.1111/j.1749-6632.2002.tb04617.x. Ann N Y Acad Sci. 2002. PMID: 12485845 No abstract available.
Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways.
Matter N, Marx M, Weg-Remers S, Ponta H, Herrlich P, König H. Matter N, et al. J Biol Chem. 2000 Nov 10;275(45):35353-60. doi: 10.1074/jbc.M004692200. J Biol Chem. 2000. PMID: 10958793
Stage-specific alternative cplicing of CD44 and alpha 6 beta 1 integrin in colorectal tumorigenesis.
Wittig BM, Goebel R, Weg-Remers S, Pistorius G, Feifel G, Zeitz M, Stallmach A. Wittig BM, et al. Exp Mol Pathol. 2001 Apr;70(2):96-102. doi: 10.1006/exmp.2000.2337. Exp Mol Pathol. 2001. PMID: 11263953
Specific N-terminal mutations in the human androgen receptor induce cytotoxicity.
Funderburk SF, Shatkina L, Mink S, Weis Q, Weg-Remers S, Cato AC. Funderburk SF, et al. Among authors: weg remers s. Neurobiol Aging. 2009 Nov;30(11):1851-64. doi: 10.1016/j.neurobiolaging.2007.12.023. Epub 2008 Mar 5. Neurobiol Aging. 2009. PMID: 18289734
Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
Weg-Remers S, Anders M, von Lampe B, Riecken EO, Schüder G, Feifel G, Zeitz M, Stallmach A. Weg-Remers S, et al. Eur J Cancer. 1998 Sep;34(10):1607-11. doi: 10.1016/s0959-8049(98)00177-4. Eur J Cancer. 1998. PMID: 9893637
Expression of CD44v6 has no prognostic value in patients with colorectal cancer.
Jüngling B, Menges M, Goebel R, Wittig BM, Weg-Remers S, Pistorius G, Schilling M, Bauer M, König J, Zeitz M, Stallmach A. Jüngling B, et al. Among authors: weg remers s. Z Gastroenterol. 2002 Apr;40(4):229-33. doi: 10.1055/s-2002-25152. Z Gastroenterol. 2002. PMID: 11961731
CD44 expression in colorectal cancer.
Weg-Remers S, Schüder G, Zeitz M, Stallmach A. Weg-Remers S, et al. Ann N Y Acad Sci. 1998 Nov 17;859:304-6. doi: 10.1111/j.1749-6632.1998.tb11151.x. Ann N Y Acad Sci. 1998. PMID: 9928409 No abstract available.
Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6.
Weg-Remers S, Hildebrandt U, Feifel G, Moser C, Zeitz M, Stallmach A. Weg-Remers S, et al. Am J Gastroenterol. 1998 May;93(5):790-4. doi: 10.1111/j.1572-0241.1998.226_a.x. Am J Gastroenterol. 1998. PMID: 9625129
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page